Ventricular Septal Defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Speech Delay
|
0.010 |
Biomarker
|
disease |
BEFREE |
The deletion affects three genes (GPR63, NDUFA4 and KLHL32) and overlaps a region previously found deleted in a girl with autistic features and speech delay.
|
23253088 |
2012 |
Severe intellectual disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Retinitis Pigmentosa
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Progressive spastic paraplegia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Progressive cerebellar ataxia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Peripheral Nervous System Diseases
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Optic Atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ophthalmoplegia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
These 14 differentially expressed genes, only 6 of which have previously been associated with RCC, are related to tumour growth/survival (EGFR, cyclin D1, insulin-like growth factor-binding protein-1 and a MLRQ sub-unit homologue of the NADH:ubiquinone oxidoreductase complex), angiogenesis (vascular endothelial growth factor, endothelial PAS domain protein-1, ceruloplasmin, angiopoietin-related protein 2) and cell adhesion/motility (protocadherin 2, cadherin 6, autotaxin, vimentin, lysyl oxidase and semaphorin G).
|
11720477 |
2001 |
Neoplasm Metastasis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Mechanism aspect, global gene expression analysis showed that downregulation of NDUFA4, a novel target of miR-7, contributed to the effects of miR-7 expression operated by TTF-1 promoter on the growth and metastasis of human lung cancer cells, as well as altered transduction of the Akt and Erk pathway.
|
28325285 |
2017 |
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Mood swings
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of colon and/or rectum
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
|
30348529 |
2018 |
Leukodystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Increased serum lactate
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased CSF lactate
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypertrophic Cardiomyopathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypertrichosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|